103 related articles for article (PubMed ID: 24440708)
1. Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.
Jöris MM; Lankester AC; von dem Borne PA; Kuball J; Bierings M; Cornelissen JJ; Sijnke ME; van der Holt B; van Rood JJ; Oudshoorn M; Claas FH
Transpl Immunol; 2014 Mar; 30(2-3):59-64. PubMed ID: 24440708
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development.
Dolezalová L; Vraná M; Dobrovolná M; Loudová M; Cukrová V; Vítek A; Sajdová J; Starý J; Sedlácek P
Neoplasma; 2002; 49(1):26-32. PubMed ID: 12044056
[TBL] [Abstract][Full Text] [Related]
3. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
4. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.
Heemskerk MB; Cornelissen JJ; Roelen DL; van Rood JJ; Claas FH; Doxiadis II; Oudshoorn M
Bone Marrow Transplant; 2007 Aug; 40(3):193-200. PubMed ID: 17529995
[TBL] [Abstract][Full Text] [Related]
5. A proposed algorithm predictive for cytotoxic T cell alloreactivity.
Jöris MM; van Rood JJ; Roelen DL; Oudshoorn M; Claas FH
J Immunol; 2012 Feb; 188(4):1868-73. PubMed ID: 22262656
[TBL] [Abstract][Full Text] [Related]
6. T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
Kircher B; Niederwieser D; Gächter A; Lindner B; Mitterschiffthaler A; Urban C; Greinix H; Peters C; Lätzer K; Gastl G; Nachbaur D
Int J Lab Hematol; 2008 Dec; 30(6):499-507. PubMed ID: 18522713
[TBL] [Abstract][Full Text] [Related]
7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
8. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
9. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
Speiser DE; Löliger CC; Siren MK; Jeannet M
Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation.
van der Meer A; Joosten I; Schattenberg AV; de Witte TJ; Allebes WA
Br J Haematol; 2000 Nov; 111(2):685-94. PubMed ID: 11122122
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
[TBL] [Abstract][Full Text] [Related]
13. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
14. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
15. Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.
Kosmoliaptsis V; Jöris MM; Mallon DH; Lankester AC; von dem Borne PA; Kuball J; Bierings M; Cornelissen JJ; Groenendijk-Sijnke ME; van der Holt B; Bradley JA; Oudshoorn M; van Rood JJ; Taylor CJ; Claas FH
Bone Marrow Transplant; 2015 Apr; 50(4):540-4. PubMed ID: 25621806
[TBL] [Abstract][Full Text] [Related]
16. Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Komarnicki M; Gil L; Czyż A; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange AA;
Am J Hematol; 2014 Oct; 89(10):E176-83. PubMed ID: 25044365
[TBL] [Abstract][Full Text] [Related]
17. Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression.
Israeli M; Roelen DL; Carrington M; Petersdorf EW; Claas FH; Haasnoot GW; Oudshoorn M
Front Immunol; 2014; 5():547. PubMed ID: 25386183
[TBL] [Abstract][Full Text] [Related]
18. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
19. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
Hirosawa T; Torikai H; Yanagisawa M; Kamei M; Imahashi N; Demachi-Okamura A; Tanimoto M; Shiraishi K; Ito M; Miyamura K; Shibata K; Kikkawa F; Morishima Y; Takahashi T; Emi N; Kuzushima K; Akatsuka Y
Cancer Sci; 2011 Jul; 102(7):1281-6. PubMed ID: 21466613
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing.
Giebel S; Giorgiani G; Martinetti M; Zecca M; Maccario R; Salvaneschi L; Holowiecki J; Locatelli F
Bone Marrow Transplant; 2003 Jun; 31(11):987-93. PubMed ID: 12774049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
